The aim of the current study was to investigate the influence of p21 on NAFLD in a FFA-induced cell model, which may help elucidate the mechanism involved in the progression of the disease. The gene discussed is CDKN1A; the disease is metabolic dysfunction-associated steatotic liver disease.